Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomized double-blind, double dummy, placebo-controlled, parallel-group, multicenter dose ranging study to evaluate the efficacy and safety of GW685698X inhalation powder once daily and fluticasone propionate inhalation powder twice daily compared with placebo for 8 weeks in adolescent and adult subjects with persistent asthma symptomatic on low-dose ICS therapy

Next Previous
X
Search
Trial Profile

A randomized double-blind, double dummy, placebo-controlled, parallel-group, multicenter dose ranging study to evaluate the efficacy and safety of GW685698X inhalation powder once daily and fluticasone propionate inhalation powder twice daily compared with placebo for 8 weeks in adolescent and adult subjects with persistent asthma symptomatic on low-dose ICS therapy

Status: Completed
Phase of Trial: Phase II

Latest Information Update: 05 Sep 2023

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Fluticasone furoate (Primary) ; Fluticasone propionate
  • Indications Asthma
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline; GlaxoSmithKline Research & Development; GSK

    • Most Recent Events

    • 30 May 2019 This trial has been completed in Poland, according to European Clinical Trials Database.
    • 18 May 2011 Results presented at the 107th International Conference of the American Thoracic Society.
    • 22 Sep 2010 Results presented at the European Respiratory Society congress, accoding to a GSK media release.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top